Topic Listing for Encorium Group

Accounting Tax Consequences Accounts Receivable
Accrued Expenses Other Acknowledgment
Acquisitions Actions Inspections Regulatory Authorities Cause Clients Not Award
Adverse Changes General Economic Political Conditions Major Countries Advertising Costs
Aggregate Exercise Price Aggregated Year-end Option Values
Agreement Agreement Candor Partners Formerly Penn Valley Management Group
Alison Oneill Amended Restated Non-qualified Stock Option Award Agreement
Amendment Amendment Form 10-k
Annual Compensation Annual Report
Annual Report Stockholders Appear Tenant Procedural Errors Proceedings Taken Landlord Whether
Applicable Price Assessment Cro Sector Marketplace Future Opportunity
Assignment Associated Companies
Assumptions Attorney Court Record Appear Tenant Suits Actions Brought
Audit Committee Audit Committee Financial Expert
Authorized Share Failure Available Sale Investments
Backlog Backlog Not Indicative Future Results
Base Salary Base Salary 2006
Base Salary 2007 Basis Presentation
Bear Financial Losses Because Contracts Delayed Terminated Reduced Becomes Encorium Group Completes Combination Remedium
Being Filed Solely Add Additional Information Regarding Beneficial Ownership Reporting Compliance
Benefits Change Control Payment Berwyn 2009
Biostatistics Bioterrorism Vaccine Program
Black Scholes Value Board Directors Recommends Vote Ratification Appointment Deloitte Touche
Board Directors Remedium Bonuses Benefits Change Control Payment
Branded Pharmaceutical Biotechnology Generic Drug Medical Device Companies Business
Business Financial Highlights Business Highlights
Business Other Financial Highlights Business Risks
Business Strategy Contemplates Future Acquisitions Result Incurring Unanticipated Business Subject International Economic Political Other Risks Negatively
Buy-in Buy-in Price
Cash Equivalents Cashless Exercise
Ceo Compensation Certain Relationships Related Transactions
Certificate Incorporation Covalent Group Inc Certification Chief Executive Officer
Certification Chief Financial Officer Certification Pursuant
Challenge Globalization Encoriums Vision Changes Governmental Regulation Reduce Need Services Provide Negatively
Changes Internal Control Over Financial Reporting Changes Outsourcing Trends Pharmaceutical Biotechnology Industries Materially Adversely
Charges Check Appropriate Box Below Form 8-k Filing Intended
Clients Marketing Clinical Trials Management
Closing Sale Price Code Business Conduct Ethics
Code Ethics Code Ethics Senior Financial Officers
Combination Agreement Remedium Combined Operations
Combined Re-named Encorium Group Inc Commitments Contingencies
Committees Board Common Stock
Common Stock Deemed Outstanding Common Stock Not Continue Qualify Exemption Penny Restrictions
Common Stock Warrants Compared 2002
Compared 2003 Compared 2004
Compared 2005 Compared 2006
Compared 2007 Compared 2008
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Directors
Compensation Discussion Analysis Compensation Philosophy
Compensation Policies Compensation Programs
Competition Completion Acquisition Disposition Assets
Components Compensation Comprehensive Income
Concentration Credit Risk Conclusion Regarding Effectiveness Disclosure Controls Procedures
Conference Call Consent Independent Registered Public Accounting Firm
Consideration Before Post Closing Adjustments Consideration Direct Transaction Costs
Consolidation Consultants
Consummation Merger Linkcon Subject Further Risks Inherent Foreign Contact Investor Relations Counsel
Contained Lease Not Liability Therefor Continuation Employment Engagement
Continuing Operations Contractual Arrangements
Contractual Obligations Commitments Controls Procedures
Convertible Securities Corporate Event
Costs Estimated Earnings Excess Billings Covalent Group Inc
Covalent Preliminary Proxy Statement Creation Direct Financial Obligation Off Balance Sheet
Creation Direct Financial Obligation Off-balance Sheet Arrangement Credibility Clinical Research Marketplace
Critical Accounting Policies Estimates Currently Fail Meet Nasdaqs Listing Requirements Common Stock
Currently Not Compliance Nasdaqs Audit Committee Requirement Set Customer Advances
Data Management Services Date Grant Term Option
Date Report Earliest Event Reported 2005 Death
Definitions Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Certain Depend Small Number Industries Clients Business Loss Significant
Description Business Description Transactions
Details Transaction Development New Drugs
Difficulty Obtaining Director Officer Liability Insurance Acceptable Amounts Dilutive Issuance
Director Compensation Director Independence
Director Nominations Directors
Directors Compensation Directors Executive Officers Registrant
Disability Discretionary Cash Bonus
Discretionary Cash Compensation Distribution
Dividend Policy Documents Incorporated Reference
Drug Biologics Development Programs Result Potential Liability Dtc
Each Party Hereby Irrevocably Waives Right Agrees Not Each Person Solicited Hereunder Obtain Copy Annual Report
Each Person Solicitied Hereunder Obtain Copy Annual Report Earnings Loss Per Share
Earnings Per Share Eighth Amendment Lease
Eligible Market Employee Benefits
Employees Employment Agreement
Employment Agreement Borow Employment Agreement Ginsberg
Employment Agreement Lindevall Employment Agreement Termination Change-in-control Arrangement
Employment Agreements Employment Forms
Employment Severance Non-compete Agreements Encorium
Encorium Announces Receipt Letters Nasdaq Regarding 2009 Form Encorium Group Completes Combination Remedium
Encorium Group Inc Encorium Group Inc Property
Encorium Group Ltd Encorium Growth Model
Encorium Growth Opportunities Geographical Expansion Encorium Growth Opportunities Phase Development Drugs Biologics
Encorium Growth Opportunities Therapeutic Area Encorium Management
End Financial Results Entering Material Definitive Agreement
Entire Agreement Entry Material Definitive Agreement
Equity Awards Equity Compensation Plan Information
Equity Incentive Plan Equity Incentive Plans
Estimated Backlog 2009 Estimates
Exact Name Registrant Specified Charter Exchange Cap
Exchange Cap Allocation Exchange Original Warrant
Excise Tax Gross Executed Registered Holder Exercise Warrant Purchase Common Stock
Executive Compensation Executive Officers
Executive Severance Agreement Exercise Delivery Documents
Exercise Notice Exercise Option
Exercise Options Exercise Price
Exhibits Exhibits Financial Statement Schedules
Expenses Solicitation Experienced Management
Expiration Date Explanatory
Exposure Substantial Personal Injury Claims Not Adequate Insurance Failure Comply 404 Sarbanes-oxley Act Negatively Impact Market
Failure Comply Existing Regulations Harm Reputation Operating Results Failure Develop New Business Intensely Competitive Industry Cause
Failure Satisfy Nasdaq Capital Market Maintenance Criteria Negatively Failure Satisfy Nasdaq Smallcap Market Maintenance Criteria Negatively
Fin Financial Assets
Financial Business Highlights Financial Highlights
Financial Income Expense Financial Instruments
Financial Operational Management Services Financial Position
Financial Results Financial Statements
Financial Statements Exhibits Financials Financial Targets
Fixed Price Nature Contracts Negative Impact Operating Results Foregoing Description Qualified Entirety Reference Amended Restated Combination
Foreign Currency Exchange Risk Foreign Currency Translation
Foreign Currency Translations Form 10-k
Form 10-k Annual Report Form 10-q
Form Lock-up Agreement Form Opinion Remedium Counsel
Form Opinion Wolf Block Form Timing Severance Benefits
Former Name Address Changed Since Last Former Name Address Changed Since Last Report
Forward Looking Statements Full Financial Results
Fundamental Transaction Future Acquisitions Disrupt Ongoing Business Distract Management Employees
General General Information
Glenhardie Partners Global Capabilities
Going Concern Goodwill Intangible Assets
Goodwill Other Intangible Assets Goodwill Other Intangibles
Governing Law Government Regulation
Health Welfare Employee Benefits Plans Held 2005
Held 2007 Held 2008
Highlights Highlights Forward Looking Statements
Highlights Proposed Combination Highlights Proposed Transaction
Hold Conference Call 900 Wednesday 2006 Holder
Holders However
Http Investorshareholdercom Media Eventdetailcfmmediaid27939cencomediakey134c0aabe8b6bf22a36136f295357721e0 Http Investorshareholdercom Media Eventdetailcfmmediaid30419cencomediakey8d0ccc8056bf006ac8e8cdd8b7d1d4a1e0
Impairment Carrying Value Intangible Assets Changes Accounting Estimates Important Information-please Read
Inability Forecast Revenue Pipeline Convert Contracts Increase Fluctuations Incentive Plans Deferred Compensation
Incentive Stock Award Agreement Incentive Stock Option Award Agreement
Income Taxes Incur Additional Impairment Charges Adversely Affect Results Operations
Incur Significant Expenses Related Proposed Acquisition Prologue Merger Incur Significant Expenses Related Proposed Sale Assets Business
Incur Significant Expenses Related Proposed Sale Encorium Indemnification Agreement
Independent Public Accountants Index
Individual Grants Industry Overview
Inflation Intellectual Property
Interaction Consultants Introduction Pro Forma Condensed Combined Consolidated Financial Statements
Investigator Advances Investment Representations
Investor Conference Call Investor Relations Counsel
Kenneth Borow Lawrence Hoffman
Lease Tenants Right Legal Remedies
Line Credit Liquidity Capital Resources
Lock-up Agreement Long-term Incentive Compensation
Lose Clients Result Uncertainty Regarding Acquisition Prologue Merger Lose Clients Result Uncertainty Regarding Proposed Sale Assets
Lose Clients Result Uncertainty Regarding Proposed Sale Encorium Loss Key Personnel Failure Attract Retain Additional Cause
Management Outlook Managements Annual Report Internal Control Over Financial Reporting
Market Information Market Price Common Stock Decline Result Consummation Proposed
Market Risk Market Stand-off
Medical Regulatory Affairs Meetings Board Directors
Method Exercise Method Payment
Might Lose Business Opportunities Result Healthcare Reform Miscellaneous
Mission Provide Value Added Services Clients Name Person Filing Proxy Statement Other Registrant
Names Shareholders Nature Option
Need Additional Capital Fund Future Operations Net Revenue
New Director Backgrounds Non-qualified Stock Option Award Agreement
Non-transferability Option Not Able Complete Acquisition Prologue Merger Linkcon Cause
Not Able Complete Sale Assets Business Encorium Not Able Complete Sale Wholly-owned Subsidiary Encorium
Not Able Identify Complete Transactions Attractive Acquisition Candidates Not Intend Pay Dividends
Notes Notes Consolidated Financial Statements
Nothing Agreement Limits Executives Right Charge Participate Investigative Now Therefore
Number 0-21145 Number Shares Remedium Stock Owned
Off Balance Sheet Financing Arrangements Officers Certificate
Operating Expenses Operating Results Expected Fluctuate Period
Operating Results Fluctuated Between Continue Fluctuate Future Operations Interrupted Occurrence Natural Disaster Other Catastrophic Event
Option Exchange Agreement Option Exercise Price
Option Grant Table Option Repricing
Options Organic Net Revenue Growth Anticipated 2007
Organization Other Compensation
Other Events Other Liabilities
Other Matters Other Periodic Reports Securities Exchange Act 1934
Other Shares Common Stock Outstanding Equity Awards Year-end
Overview Paid Time Off
Parent Entity Part
Part Certification Contracts Rights Parties Act Break Clause Part Definitions Interpretation
Part Demise Part Forfeiture
Part Guarantee Part Landlords Covenants
Part Miscellaneous Provisions Part Other Information
Partial Exercise Patient Registries
Payment Obligation Payments Former Stockholders Remedium
Pensions Percentage Net Revenue Excluding Reimbursable Out-of-pocket Expenses
Perception Not Able Continue Going Concern Adversely Affect Performance Graph
Perquisites Person
Pierrel Research Usa Inc Plan
Plan Distribution Please Date Sign Enclosed Proxy Being Solicited Board
Policy Pre-approval Audit Non-audit Services Possible
Post-closing Adjustments Potential Liability Insurance
Potential Payments Termination Change-in-control Preliminary Estimate Allocation Purchase Price
Prepaid Expenses Other Principal Accountant Fees Services
Principles Consolidation Pro Forma Adjustments
Pro Forma Adjustments Statement Operations Process Implementing Plans Reducing Expenses Fail Achieve Results
Profit Sharing 401 Plan Property Equipment
Proposal 1-election Directors Proposal Election Directors
Proposal Two- Ratification Appointment Independent Auditors Proposal Two-ratification Appointment Independent Auditors
Proposed Acquisition Remedium Proposed Future Laws Regulations Including Confidentiality Patient Information
Proposed Future Laws Regulations Including Relating Confidentiality Patient Proposed Sale Assets Business Encorium Not Result Premium
Proposed Sale Encorium Not Result Premium Current Stock Proposed Sale Encorium Not Result Premium Less Current
Provided However Proxy Statement
Proxy Statement Encorium Each Refers Group Inc Delaware Purchase Price Allocation
Purchase Rights Purpose Meeting
Pursuant 302 Sarbanes-oxley Act 2002 Pursuant 906 Sarbanes-oxley Act 2002
Quality Assurance Compliance Quantitative Qualitative Disclosures Market Risk
Quarterly Period 2005 Recent Sales Unregistered Securities
Recently Issued Accounting Standards Reclassifications
Record Date Voting Securities Registrants Telephone Number Including Area Code 610 975-9533
Registrants Telephone Number Including Area Code 610-975-9533 Registration Rights Agreement
Registration Statement Reimbursable Out-of-pocket Expenses
Reiterates Expected 3q2006 Operating Profitability Reiterates Guidance
Related Parties Relocation Expense
Remedium Remedium Acquisition Disrupt Ongoing Business Distract Management Employees
Report Audit Committee Report Compensation Committee
Report Compensation Committee Board Directors Report Independent Registered Public Accounting Fir
Report Independent Registered Public Accounting Firm Report Writing
Representations Warranties Covalent Representations Warranties Option Holders
Repricing Options Required Reserve Amount
Restricted Cash Restrictions Exercise
Results Operations Revenue Recognition
Revenues Earnings Exposed Exchange Rate Fluctuations Well International Revocability Proxies
Right Exercise Risk Factors
Role Neos Setting Compensation Sab 108
Safe Harbor Statement Salary
Sarbanes-oxley Act 2002 Schedule
Schedule Buyers Schedule Exceptions Reservations
Schedule Incumbrances Schedule Regulations
Schedule Rights Schedule Services
Schedules Secretarys Certificate
Securities Authorized Issuance Equity Compensation Plans Securities Exchange Act 1934
Securities Exchange Act 1934 Amendment Securities Purchase Agreement
Securities Registered Exchange Act Security Ownership Certain Beneficial Owners Management Related Stockholder
Selling Stockholders Separation Mutual Release Agreement
Services Seventh Amendment Lease
Severability Severance Agreement Ginsberg
Severance Agreement Lawrence Hoffman Severance Agreement Lindevall
Severance Agreements Severance Benefits
Sfas 123r Sfas 155
Sfas 156 Sfas 157
Sfas 158 Share Delivery Date
Share-based Compensation Shareholder Communications
Signa Tures Signature
Signature Page Follows Signatures
Sixth Amendment Lease Solicited Behalf Board Directors
Space Intentionally Left Blank Signature Page Follows Status Proposed Acquisition Remedium
Stock Based Compensation Stock Options
Stock Price Continue Experience Fluctuations Stock Price Volatile Experience Substantial Declines
Stock-based Compensation Stockholder Proposals 2006 Annual Meeting Stockholders
Stockholders Suffer Immediate Substantial Dilution Equity Voting Interests Stockholders Unable Attend Meeting Person Asked Vote Sign
Strategic Benefits Objectives Transaction Strategic Objectives Including New Business Model
Strategy Strong Financial Position
Study Protocol Design Submission Matters Vote Security Holders
Subsequent Events Subsidiaries
Substantial Exposure Currency Risks Substantial Non-us Operations Expose Currency Risks
Success Depends Ability Keep Pace Rapid Technological Changes Success Proposed Acquisition Prologue Merger Linkcon Depend Retention
Successors Suite 100 Wayne Pennsylvania
Summary Compensation Table Summary Selected Pro Forma Condensed Combined Consolidated Financial
Supplemental Cash Flow Information Table Contents
Tax Valuation Allowance Technology Life Science Companies
Tenant Please Initial Here Tenant Shall Default Payment Rent Other Sums Due
Termination Termination Cause
Termination Relationship Through Private Placement Common Stock Warrants
Title Class Tock
Trading Transaction Details
Transfer Agent Treasury Stock
Uab Encorium Lithuania Unable Attract Suitable Willing Volunteers Clinical Trials Clients
Unable Quickly Effectively Integrate Operations Materially Adversely Affect Unable Safeguard Networks Clients Data Not Services Business
Unable Successfully Develop Market New Services Internationally Results Unable Successfully Develop Market New Services United States
Underlettings United States
Unregistered Sales Equity Securities Valuation Event
Valuation Expense Information Sfas 123 Via Fax
Voting Solicitation Warrant
Warrant Exchange Agreement Warrant Shares
Wayne 2008 Encorium Group Inc Nasdaq Enco Wayne 2009 Encorium Group Inc Nasdaq Enco
Weighted Average Price Whereas
Withholding Witness Whereof
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki